← Back to Search

Virtual Reality for Pre-Surgery Anxiety in Children

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient with age range from 6 to 25
Able to consent or have parental consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of intervention, approximately 20-30 minutes
Awards & highlights

Study Summary

This trial studies how virtual reality can help pediatric patients and their adult caregivers feel more awe before surgery.

Who is the study for?
This trial is for hospitalized children aged 6-25 facing surgery and their adult caregivers, who can consent in English. It's not for those with severe motion sickness, cognitive impairments, visual issues, current nausea or a history of seizures.Check my eligibility
What is being tested?
The study tests how virtual reality (VR) might help reduce anxiety in kids before operations and their caregivers. Participants will either experience VR designed to awe or be part of a control group without VR.See study design
What are the potential side effects?
Since this trial involves the use of Virtual Reality, side effects may include temporary discomfort like dizziness or headaches due to motion sickness but are generally minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of intervention, approximately 20-30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of intervention, approximately 20-30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in awe levels measured by Global Perceived Awe Survey
Secondary outcome measures
Change in awe levels measured by Perceived Need for Accommodation Survey
Change in awe levels measured by Perceived Vastness Survey
Change in engagement measured by Game Engagement Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Group I: Virtual RealityExperimental Treatment1 Intervention
Virtual reality intervention will be given 6 times in total and each session will last not more than 60 seconds.
Group II: ControlExperimental Treatment1 Intervention
Participants will serve as their own controls. Participants will not be given any VR intervention at first but they are requested to fill out the survey to collect the baseline data.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1630

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
17,343,205 Total Patients Enrolled
33 Trials studying Anxiety
22,925 Patients Enrolled for Anxiety

Media Library

Virtual Reality Clinical Trial Eligibility Overview. Trial Name: NCT05743062 — N/A
Anxiety Research Study Groups: Control, Virtual Reality
Anxiety Clinical Trial 2023: Virtual Reality Highlights & Side Effects. Trial Name: NCT05743062 — N/A
Virtual Reality 2023 Treatment Timeline for Medical Study. Trial Name: NCT05743062 — N/A
~105 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top